Determination of platinum in human subcellular microsamples by inductively coupled plasma mass spectrometry

被引:15
作者
Bjorn, Erik [1 ]
Nygren, Yvonne
Nguyen, Tam Trinh Thi Nhu
Ericson, Christer
Nojd, Mikael
Naredi, Peter
机构
[1] Umea Univ, Dept Chem, S-90187 Umea, Sweden
[2] Umea Univ Hosp, Dept Surg, S-90185 Umea, Sweden
关键词
platinum; cisplatin; ICPMS; human subcellular microsamples; DNA; exosomes;
D O I
10.1016/j.ab.2007.01.006
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
A fast and robust method for the determination of platinum in human subcellular microsamples by inductively coupled plasma mass spectrometry was developed, characterized, and validated. Samples of isolated DNA and exosome fractions from human ovarian (2008) and melanoma (T289) cancer cell lines were used. To keep the sample consumption to approximately 10 mu l and obtain a high robustness of the system, a flow injection sample introduction system with a 4.6-mu l sample loop was used in combination with a conventional pneumatic nebulizer and a spray chamber. The system was optimized with respect to signal/noise ratio using a multivariate experimental design. The system proved to be well suited for routine analysis of large sample series, and several hundreds of samples could be analyzed without maintenance or downtime. The detection limit of the method was 0.12 pg (26 pg/g) platinum. To avoid systematic errors from nonspectral interferences, it was necessary to use reagent matched calibration standards or isotope dilution analysis. An uncertainty budget was constructed to estimate the total expanded uncertainty of the method, giving a quantification limit of 2.3 pg (0.5 ng/g) platinum in DNA samples. The uncertainty was sufficiently low to study quantitative differences in the formation of Pt-DNA adducts after treatment with cisplatin using different exposure times and concentrations. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 25 条
[1]
ANDREWS PA, 1990, CANCER CELL-MON REV, V2, P35
[2]
ICP-MS determination of Pt in biological fluids of patients treated with antitumor agents: evaluation of analytical uncertainty [J].
Bettinelli, M .
MICROCHEMICAL JOURNAL, 2005, 79 (1-2) :357-365
[3]
Calibration errors due to variations in peak characteristics in the measurement of transient signals by inductively coupled plasma-scanning mass spectrometry [J].
Björn, E ;
Baxter, DC ;
Frech, W .
JOURNAL OF ANALYTICAL ATOMIC SPECTROMETRY, 2002, 17 (12) :1582-1588
[4]
Bonetti A, 1996, CLIN CANCER RES, V2, P1829
[5]
[Ellison S.L.R. EURACHEM/CITAC EURACHEM/CITAC], 2000, Quantifying Uncertainty in Analytical Measurement
[6]
Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS) [J].
Ghezzi, A ;
Aceto, M ;
Cassino, C ;
Gabano, E ;
Osella, D .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2004, 98 (01) :73-78
[7]
Platinum determination by inductively coupled plasma-sector field mass spectrometry (ICP-SFMS) in different matrices relevant to human biomonitoring [J].
Hann, S ;
Koellensperger, G ;
Kanitsar, K ;
Stingeder, G ;
Brunner, M ;
Erovic, B ;
Müller, M ;
Reiter, C .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2003, 376 (02) :198-204
[8]
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals [J].
Ishida, S ;
Lee, J ;
Thiele, DJ ;
Herskowitz, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (22) :14298-14302
[9]
Tumour-inhibiting platinum complexes-state of the art and future perspectives [J].
Jakupec, MA ;
Galanski, M ;
Keppler, BK .
REVIEWS OF PHYSIOLOGY, BIOCHEMISTRY AND PHARMACOLOGY, VOL 146, 2003, 146 :1-53
[10]
Johnsson A, 1998, CANCER CHEMOTH PHARM, V41, P248